BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9581673)

  • 1. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.
    Piton A; Poynard T; Imbert-Bismut F; Khalil L; Delattre J; Pelissier E; Sansonetti N; Opolon P
    Hepatology; 1998 May; 27(5):1213-9. PubMed ID: 9581673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study.
    Kariv R; Leshno M; Beth-Or A; Strul H; Blendis L; Kokia E; Noff D; Zelber-Sagie S; Sheinberg B; Oren R; Halpern Z
    Liver Int; 2006 May; 26(4):445-50. PubMed ID: 16629648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis.
    Di Bonito P; Sanguigno E; Di Fraia T; Forziato C; Boccia G; Saitta F; Iardino MR; Capaldo B
    Metabolism; 2009 Mar; 58(3):368-72. PubMed ID: 19217453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
    Grunenberg R; Banik N; Krüger J
    Infusionsther Transfusionsmed; 1995 Jun; 22(3):145-51. PubMed ID: 7640509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
    Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
    J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of serum alanine-aminotransferase levels in blood donors in Spain.
    Lozano M; Cid J; Bedini JL; Mazzara R; Gimenez N; Mas E; Ballesta A; Ordinas A
    Haematologica; 1998 Mar; 83(3):237-9. PubMed ID: 9573678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients.
    Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Kao JH; Chen DS
    Liver Int; 2008 Aug; 28(7):1034-41. PubMed ID: 18492018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
    Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
    Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of serum alanine aminotransferase (ALT) to body weight, age and sex in blood donors population].
    Morańska I; Jurczyk K; Kłosińska E; Wiśniewski K; Karpińska E; Wawrzynowicz-Syczewska M; Urbanowicz W; Rzechuła H; Boroń-Kaczmarska A
    Wiad Lek; 2004; 57(9-10):427-30. PubMed ID: 15765756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum alanine aminotransferase levels among volunteer blood donors: effect of sex, alcohol intake and obesity.
    Bizzaro N; Tremolada F; Casarin C; Bonetti P; Noventa F; Diodati G; Drago C; Realdi G
    Ital J Gastroenterol; 1992 Jun; 24(5):237-41. PubMed ID: 1623221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
    Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors.
    Pourshams A; Malekzadeh R; Monavvari A; Akbari MR; Mohamadkhani A; Yarahmadi S; Seddighi N; Mohamadnejad M; Sotoudeh M; Madjlessi A
    J Gastroenterol Hepatol; 2005 Feb; 20(2):229-33. PubMed ID: 15683425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects.
    Wu WC; Wu CY; Wang YJ; Hung HH; Yang HI; Kao WY; Su CW; Wu JC; Chan WL; Lin HC; Lee FY; Lee SD
    Aliment Pharmacol Ther; 2012 Sep; 36(6):560-8. PubMed ID: 22817613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C.
    Sanai FM; Helmy A; Dale C; Al-Ashgar H; Abdo AA; Katada K; AlMana H; Saadeh M; Al-Hussaini H; AlQuaiz M; Hashem A; AlSwat K; Bzeizi KI; Marotta PJ
    Liver Int; 2011 Aug; 31(7):1039-46. PubMed ID: 21733094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
    Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
    J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S
    Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.
    Bressler BL; Guindi M; Tomlinson G; Heathcote J
    Hepatology; 2003 Sep; 38(3):639-44. PubMed ID: 12939590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy.
    Arase Y; Ikeda K; Tsubota A; Suzuki Y; Saitoh S; Kobayashi M; Suzuki F; Akuta N; Someya T; Hosaka T; Kobayashi M; Kumada H
    J Gastroenterol; 2004; 39(5):455-60. PubMed ID: 15175944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.